BSE filing, NSE: PVP. Summary written from the filing by ALFA Finder's alert engine.
PVP Ventures Ltd: key numbers
- Share price
- ₹45.96
- Market cap
- ₹1,197 Cr
- Revenue (annual)
- ₹89.71 Cr
- Net profit (annual)
- ₹-6.80 Cr
- P/E (TTM)
- 239.6×Sector 33.7×
- Promoter holding
- 61.30%+0.00% QoQ
- FII holding
- 0.81%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from PVP Ventures Ltd
All →PVP Ventures Bags ₹142.2 Cr Order from Elekta Solutions AB
PVP Ventures won a ₹142.15 Crore order from Sweden's Elekta Solutions AB for 10 HARMONY LINAC systems. Phased delivery is expected by October 2028.
- Value
- ₹142.2 Cr
- From
- Elekta Solutions AB
- Execution
- Phased delivery of 5+5 units, tentatively by October 2028
- medical linear accelerator units
- 10 LINAC systems
PVP Ventures Business Update
Evervie Health Limited signed an LOI to procure 10 LINAC systems from Elekta Solutions AB, valued at approximately $11–15 million (₹104.5–142.5 Crore).
- Value
- ₹104.5 Cr
- LINAC systems
- 10.0 units
PVP Ventures Other Announcement
Everyvie Health (formerly PVP Ventures) filed its Reg 76 share capital reconciliation report for Q2 FY27. No transaction or capital change is reported for the quarter.
PVP Ventures Debt & Borrowing: ₹13.46 Cr
Evervie Health Limited made an advance interest payment of ₹13.46 Crore on its Non-Convertible Debentures, fulfilling its debt obligations for future scheduled payment dates.
- Value
- ₹13.46 Cr
PVP Ventures Annual Report
Evervie Health Limited submitted an updated Annual Report for FY 2025-26. This filing incorporates an addendum and corrigendum to the previously submitted report.
PVP Ventures Other Announcement
PVP Ventures Limited has officially changed its name to Evervie Health Limited, effective from 5th October, 2026, following approval from the Registrar of Companies.
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.